study question: Which non-declared proteins (proteins not listed on the composition list of the product data sheet) are present in unconditioned commercial embryo culture media? summary answer: A total of 110 non-declared proteins were identified in unconditioned media and between 6 and 8 of these were quantifiable and therefore represent the majority of the total protein in the media samples.
Introduction
Infertility is a growing problem worldwide and in some countries up to 4.5% of a cohort of children are conceived with the help of fertility treatments (Ferraretti et al., 2013) . Since only 25-30% of human embryos implant, the selection of which embryo (or embryos) to be transferred to the uterus is a critical step in IVF treatments in order to maximize the probability of pregnancy. Today, the most common method to assess the developmental and viability potential of embryos is the assessment of embryo morphology at discrete time points, a method that has several limitations. Some of these limitations, in particular the restricted, time-dependent observations and potentially subjective classification, have been overcome with the introduction of time-lapse photography (Meseguer et al., 2011; Sundvall et al., 2013) . Nevertheless, the expected benefits of morpho-kinetic analysis in terms of improved pregnancy rate have yet to be documented . Furthermore, methods that evaluate non-morphological parameters may be expected to contribute not only with additional selection criteria but also with a knowledge of other more biochemical aspects of embryo physiology and development. It is believed that selection based on both morphological assessment and non-invasive analysis may improve the success rates of IVF and facilitate single embryo transfers (Katz-Jaffe et al., 2009) . Recent strategies have involved the measurement of embryonic metabolic activity such as amino acid turnover (Houghton et al., 2002) , pyruvate and glucose uptake (Gardner et al., 2001 (Gardner et al., , 2011 , oxygen consumption (Lopes et al., 2007; Tejera et al., 2012) and the turnover of the entire metabolome (Seli et al., 2010; Hardarson et al., 2012; Vergouw et al., 2012) . However, none of these strategies has resulted in clinically applicable methods.
Analysis of the proteins produced and secreted by embryos throughout embryo development has been proposed to reflect the embryo's viability (Katz-Jaffe et al., 2009). Consequently, a deeper knowledge of which proteins are secreted by the embryo may lead to a more comprehensive assessment of embryos during their preimplantation development and aid in the selection of the most viable embryos during IVF treatments. However, the identity of the proteins secreted by human embryos is largely unknown and, despite intense and promising research, results remain conflicting and no clinical validation has been performed. This is attributed to the limited starting material and technological limitations. An important source of error may be if proteins are present in the unconditioned culture media (fresh media in which no embryos have been cultured), which could lead to misinterpretation when identifying secreted proteins. If proteins are present in the media before culture, such information should necessarily be employed as a reference in the attempt to identify proteins secreted or metabolized by human embryos. Furthermore, embryo toxic factors have been identified that result in poor embryo quality and impaired developmental growth (Dokras et al., 1993; Groebe et al., 2010) . The safety of culture media therefore makes it important to know the complete composition of the embryo culture media, and it would be advisable to test all factors for their positive and negative effects on embryo development and health effects for the offspring. The purpose of the present study was to identify and quantify non-declared proteins present in media used for human embryo culture in order to provide a protein reference set. 
Materials and Methods

Media
In-solution digestion
A total of 100 mg total protein of each media sample was lyophilized and re-dissolved in 25 ml 8 M urea 0.2 M Tris -HCl, pH 8.3, reduced and alkylated by adding 15 mM dithiothreitol (DTT) followed by the addition of 30 mM iodoacetamide. Both reactions were allowed to continue for 1 h. The samples were subsequently diluted five times with 0.1 M Tris-HCl pH 8.3 and digested using 1:50 w/w trypsin (Sigma) at 378C for 16 h. From each sample, 20 mg was desalted using Poros 50 R2 reverse phase column material (PerSeptive Biosystems) packed in GELoader Tips (Eppendorf), dried in a vacuum centrifuge, dissolved in 0.1% formic acid and stored at 48C before liquid chromatography-tandem mass spectrometry (LC -MS/ MS) analysis.
Albumin depletion
A total of 5 ml ( 25 mg serum albumin) Sydney IVF Cleavage Medium (Cook Medical, Lot: K11935) or 0.5 ml ( 25 mg serum albumin) G-MM recombinant human serum albumin (HSA) supplement (Vitrolife, Lot: 017087) was diluted four times in phosphate-buffered saline, 5 mM ethylenediaminetetraacetic acid, pH 7.4 (loading buffer) and applied to a 1 ml column containing the recombinant albumin-binding domain of streptococcal protein G (Kronvall et al., 1979) equilibrated in loading buffer. To prevent exceeding the albumin-binding capacity of the column (30 mg/ml), each diluted medium sample was divided in five fractions and each fraction was depleted separately. The flow through was collected for each run, and the column regenerated in between using wash buffer (20 mM Na-citrate, 150 mM NaCl, pH 2.5). Flow through for all runs were pooled for each media and dialyzed overnight into 10 mM Tris -HCl, pH 7.4. The depleted and dialyzed media was then concentrated using a 15 ml Centriprep 10 K centrifugal filter (Merck Millipore Ltd) to a volume of 0.5 ml before being lyophilized using a speedvac (Savant) to a final volume of 50 ml.
Protein separation by SDS -PAGE and in-gel digestion
The albumin-depleted samples were boiled for 5 min in sodium dodecyl sulfate (SDS) sample buffer containing 50 mM DTT, separated by SDS polyacrylamide gel electrophoresis (SDS -PAGE) using a 5 -15% (w/v) gel (Bury, 1981) and stained using Coomassie blue (RAPIDstain, G-Biosciences). The gel was cut into 14 slices, and these were washed three times in milli-Q water and incubated two times 15 min in 130 ml 50% acetonitrile, dehydrated in 130 ml acetonitrile for 15 min and equilibrated in 150 ml 0.1 M NH 4 HCO 3 for 5 min before 150 ml acetonitrile was added. After 15 min the supernatants were removed and the gel pieces were lyophilized for 20 min. In-gel digestions were performed by digesting the gel pieces with trypsin (Sigma) using a 1:50 (w/w) ratio in 50 mM NH 4 HCO 3 at 378C for 16 h. The resulting peptides were desalted using Poros 50 R2 reverse phase column material (PerSeptive Biosystems) packed in GELoader Tips (Eppendorf), dried in a vacuum centrifuge, dissolved in 0.1% formic acid and stored at 48C before LC -MS/MS analysis.
LC -MS/MS analysis
LC -MS/MS analyses were performed on an EASY-nLC II system (Thermo Scientific) connected to a TripleTOF 5600+ mass spectrometer (AB Sciex) equipped with a NanoSpray III source (AB Sciex) and operated under Analyst TF 1.6.0 control. The samples were injected, trapped and desalted isocratically on a Biosphere C18 precolumn (ID 100 mm × 2 cm, 5 mm, 120 Å , NanoSeparation, Nieuwkoop, Netherlands). Next, the peptides were eluted from the trap column and separated on a 15 cm analytical column (75 mm i.d.), which was pulled in-house on Polymicro silica tubing by a P2000 laser puller (Sutter Instrument Co.), and packed in-house with ReproSil-Pur C18-AQ 3 mm resin (Dr Marisch GmbH, AmmerbuchEntringen, Germany). Peptides were eluted at a flow rate of 250 nl/min using a 50 min gradient from 5 to 35% phase B (0.1% formic acid and 90% acetonitrile), followed by re-equilibration for 10 min back to the starting conditions.
Protein identification
The collected MS files were converted to Mascot generic format (MGF) using the AB SCIEX MS Data Converter beta 1.3 (AB SCIEX) and the 'proteinpilot MGF' parameters. The peak lists were used to interrogate the Swiss-Prot (version 2014_01, 542 258 sequences) Homo sapiens (20 273 sequences) database or the Swiss-Prot Fungi (31 056 sequences) database using Mascot 2.3.02 (Matrix Science) (Perkins et al., 1999) . Trypsin was employed as enzyme allowing one missed cleavage. Propionamide was entered as a fixed modification for in-gel digests and carbamidomethyl for in-solution digests, whereas oxidation of methionine, and hydroxylation of proline were entered as variable modifications. The mass accuracy of the precursor and product ions were 10 ppm and 0.2 da, and the instrument setting was specified as ESI-QUAD-TOF. The significance threshold ( p) was set at 0.01 and the ion score expect cut-off at 0.005. Mascot results were parsed using MS Data Miner v. 1.2.2 (Dyrlund et al., 2012) accepting only protein hits identified based on three or more unique peptides with expected ion values equal to or lower than 0.005. All keratin contaminants were removed from the final protein lists. MS Data Miner was further used to extract Gene Ontology (GO) information for all identified proteins. Note that since proteins are annotated with several GO terms, they can be represented in multiple GO summary categories.
Protein quantification
Proteins were quantified based on the average MS signal response for the three most intense tryptic peptides for each protein and expressed as percentage of total protein (Silva et al., 2006) . In short, the MS files were searched as listed above and the Mascot .dat result files were used to generate a spectral library in Skyline v. 2. 1.0.4936 (MacLean et al., 2010) using the human sequences from Swiss-Prot as background proteome. Employing the same parameters as for the Mascot search, the three most abundant peptides for each protein were manually chosen from all peptides available in the spectral library. After data import, the chromatographic traces (extracted ion chromatograms) were manually inspected and adjusted where needed to correct wrongfully assigned peaks. Proteins identified with ,3 peptides were not included in the quantification. The relative abundance and standard deviation of proteins quantified in all four of the technical replicates was calculated as the average MS intensity for the three peptides for each protein divided by the sum of the average signal for all quantified proteins in the sample.
Results
To examine the extent of non-declared proteins present in media used for human embryo culture, eight different embryo culture media from three different suppliers were collected and the most abundant proteins present in the media were quantified using MS. Other than HSA, between 6 and 8 proteins were quantifiable in all media samples, with relative protein amounts ranging from 0.01 to 4.7% (Table I) . The average amount of HSA present in the samples was 94.5%. Furthermore, to examine batch-to-batch variations in protein amounts, two different batches of the Sydney IVF Cleavage Medium and two of the Sydney IVF Blastocyst Medium were included in the analysis. Relative protein amounts were observed to differ with up to 1-fold indicating batch-to-batch variation (Table I ). In the purified HSA solution (HSA-solution), 18 proteins were quantifiable. These included all the proteins quantified in the other embryo culture media as well as attractin and thyroxine-binding globulin.
In order to identify low abundance proteins present in the medium, 5 ml Sydney IVF Cleavage Medium was albumin depleted before protein separation by SDS-PAGE and identification by LC-MS/MS analysis (Supplementary data, Fig. S1 ). Using high confidence criteria, a total of 111 proteins were identified (Table II) . A GO annotation analysis was performed on the proteins based on a series of summary categories (GO slim categories), including molecular function and biological processes. Based on biological process, the proteins grouped into three major groups: inflammatory response, innate immune response and response to peptide hormone stimulus. For the molecular function, five large groups were identified: enzyme inhibitor activity, ion binding, peptidase activity, receptor activity and transporter activity (to access these data, see below). Finally, 0.5 ml ( 25 mg total protein) recombinant human albumin supplement, G-MM from Vitrolife, was albumin depleted and analyzed as above. No human or yeast proteins were identified in the supplement media except for HSA.
The MS proteomics data and further MS data have been deposited with the ProteomeXchange Consortium (http://proteomecentral .proteomexchange.org) via the PRIDE partner repository (Vizcaino et al., 2013) with the dataset identifier PXD001174.
Discussion
This study demonstrates the presence of 110 proteins other than HSA in unconditioned media where only human serum albumin is declared to be 
Continued
Embryo culture media contain non-declared proteins present. Eight of these proteins have previously been suggested as biomarkers of embryonic viability (Table II) . This finding therefore has implications for the interpretation of studies of the human secretome performed on IVF embryos. Previous proteomic studies of conditioned embryo media have focused on identifying proteins secreted into the surrounding media. In a first study, Katz-Jaffe et al. used MS to identify biomarkers for embryo viability. Their analysis of individual human embryos showed that protein expression profiles could be related to morphology and thus embryo viability (Katz-Jaffe et al., 2006a,b) . In a follow-up study, the same group analyzed the human embryo secretome. They identified ubiquitin as a potential biomarker which was up-regulated in developing blastocysts compared with degenerating embryos (Katz-Jaffe et al., 2006a,b) . However, up-regulation of ubiquitin has not been correlated with pregnancy rates in IVF trials. In addition, protein microarray studies have correlated the concentration of proteins, such as C-X-C motif chemokine 13, stem-cell factor, macrophage-stimulating protein-alpha, TRAILR3, MIP-1b, soluble tumor necrosis factor receptor 1, Interleukin-10, Insulin-like growth factor I, Interleukin-1 receptor type 1, Eotaxin-3 and NT-4 to embryo viability . Microarray studies are, however, limited by their high costs, and the dependence on the existence of antibodies and their sensitivity, which means that samples from individual embryos cannot be measured (Katz-Jaffe et al., 2009). Other studies have focused on individual proteins, identifying the secretion of platelet activation factor (O'Neill, 1985) , leptin , acrogranin (Diaz-Cueto et al., 2000) and soluble human leukocyte antigen G . In total, 84 proteins have been identified as secreted by mammalian embryos, 41 of which are from human embryos (Table III) .
Our results show that even though HSA is the only protein listed as being added to embryo culture media, many other proteins are also present in the media with other proteins on average adding up to 5.5% of the total (ranging from 3.3 to 8.0%). In some samples, single proteins accounted for up to 4.7% of the total protein, making them a significant constituent of the media. With modern plasma fractionation methods, HSA can only be purified to 99% purity (Burnouf, 2007) and the 110 other identified proteins are most likely impurities in the HSA added to the embryo media. Of the identified proteins, all proteins except Myosin-1 and Myosin-4 have also been identified in human plasma (data not shown). The proteins are hence likely co-purified with serum albumin by specific or non-specific binding to serum albumin. Analysis of purified HSA from Vitrolife (HSA-solution) also showed that the proteins identified in the embryo culture media are also present in the HSAsolution. This indicates that the HAS added to IVF media is the source of contaminating proteins, and Vitrolife has confirmed that the serum albumin in their culture media is the same as in the HSA-solution. The presence of proteins other than HSA in unconditioned media makes it difficult to determine if a protein present in conditioned embryo media is truly a secreted protein. Quantitative measurements therefore have to be taken into account when analyzing the embryo's secretome.
Previous studies have shown that not all serum albumin preparations are alike (Xiao and Isaacs, 2012) and batch to batch variation in IVF embryo media is to be expected. This was examined here by analyzing two different batches of the Sydney IVF Cleavage Medium and two batches of the Sydney IVF Blastocyst Medium. Batch to batch variation in protein amounts was observed, and the relative protein amount of haptoglobin was found to vary by up to 1-fold between two batches of the Sydney IVF Blastocyst Medium (Table I) . Accordingly, it is important that experimental and control media are from the same batch when studying the embryo secretome and when analyzing conditioned embryo media with the aim of finding potential biomarkers that can distinguish normal and abnormal embryonic development. Furthermore, batch or lot numbers should preferentially be included when publishing IVF data as variations and differences in results might be a result of variations in the media.
Of the 84 proteins previously identified as secreted by embryos, the following eight are also identified in this study: afamin, apolipoprotein A-I, epidermal growth factor receptor, haptoglobin, haptoglobin-related protein, peroxiredoxin-1, serotransferrin and serum albumin (Table II) . These proteins have been shown to be increased in conditioned media compared with control media, but it is uncertain from the studies whether or not the control media are from the same batch as the conditioned embryo media. Afamin and haptoglobin were quantifiable in all analyzed media samples indicating that these proteins are present in high amounts in unconditioned embryo culture media: These two proteins were found to differ by up to 70 and 95%, respectively, between two batches, therefore indicating high differences between batches and making it easy to incorrectly identify these proteins as potentially secreted or taken up by embryos. Serotransferrin was also found to be among the most abundant proteins in three of the tested media. Regardless, it is important to know that these proteins are present in the media before embryo incubation.
IVF medium is a valuable source for proteins that can be used as biomarkers in IVF. The focus has been on secreted proteins, but the proteins already present in the medium can be equally valuable in the pursuit for biomarkers. These proteins may be necessary for embryo development, and the uptake or degradation of specific proteins might correlate to a certain embryo development or lack thereof. The 111 proteins identified in the Sydney IVF Cleavage Medium therefore have to be evaluated for their potential to differentiate embryos success rates, as all these proteins can be potential biomarkers. Additionally, the safety of these proteins in culture media for the offspring should be evaluated. Recent studies indicate a correlation between birthweight and embryo culture media (Dumoulin et al., 2010) and that the protein source might influence birthweight (Zhu et al., 2014 In order to identify a medium that is optimal for analyzing secreted embryo proteins, the recombinant human serum albumin supplement, G-MM from Vitrolife, was tested for proteins other than serum albumin. As expected, no other human proteins were identified in the media. The HSA is expressed in yeast cells but this analysis could likewise not identify any yeast proteins. The recombinant human serum albumin supplement seems to be free of contaminating proteins and is hence an ideal option for analyzing secreted embryo proteins when combined with protein-free media as well as for analyzing how the additional proteins influence embryo development.
In conclusion, this study has highlighted that the HSA added to IVF media contains many other proteins consequently making it more difficult to analyze the embryo's secretome. More notably, the proteins present in the unconditioned medium have been overlooked in previous IVF studies as a source of potential biomarkers that can distinguish normal and abnormal embryonic development based on which proteins are metabolized by human embryos. Finally, more research is needed into the effect of the identified proteins on embryonic development, and gestation age and birthweight.
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